A proposed production method for astatinated (At-211) Trastuzumab for use in a Phase I clinical trial

• Emma Aneheim ,

  Roles Conceptualization, Investigation, Methodology, Writing – original draft

  * E-mail: emma.aneheim@radfys.gu.se

  Affiliations Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, Department of Oncology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

  https://orcid.org/0000-0003-2566-886X

  ⨯
• Tom Bäck,

  Roles Conceptualization, Investigation, Methodology, Writing – review & editing

  Affiliation Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Holger Jensen,

  Roles Investigation, Methodology, Resources, Writing – review & editing

  Affiliation Department of Clinical Physiology and Nuclear Medicine, Cyclotron and Radiochemistry unit, Copenhagen University Hospital, Copenhagen, Denmark

  ⨯
• Stig Palm,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯
• Sture Lindegren

  Roles Conceptualization, Investigation, Methodology, Writing – review & editing

  Affiliation Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

  ⨯